Sign up to save your podcasts
Or
Share Considerations for Use of Two Newly Approved Drugs
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Considerations for Use of Two Newly Approved Drugs
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
View all episodes
By Modern Optometry
5
1515 ratings
Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, MBA, MS, FAAO, discuss factors to consider when bringing perfluorohexyloctane ophthalmic solution (Miebo, Bausch + Lomb) and lotilaner ophthalmic solution 0.25% (Xdemvy, Tarsus Pharmaceuticals) into your clinical practice.
More shows like To the Point
View all
Power Hour Optometry
77 Listeners
The Doctor Youn Show
1,145 Listeners
The Dr. Hyman Show
9,282 Listeners
The Peter Attia Drive
8,187 Listeners
Try Not To Blink
63 Listeners
20/20 MONEY
81 Listeners
The Everyday Style School
522 Listeners
The MOD Pod
5 Listeners
Four Eyes
19 Listeners
Optometry: The Ultimate O.D.
20 Listeners
Best Laid Plans
802 Listeners
Optometric Insights Media
21 Listeners
Dr. Streicher’s Inside Information: Menopause, Midlife, and More
364 Listeners
EYE OWN A BUSINESS
18 Listeners
Eye Give a Damn!
18 Listeners